Top

Published in:

01-02-2019 | Metastasis | Original Article

The Current Status of Peritoneal Surface Oncology in India

Authors: Aditi Bhatt, Sanket Mehta, Ramakrishnan Ayaloor Seshadri

Published in: Indian Journal of Surgical Oncology | Special Issue 1/2019

Abstract

With the increasing acceptance of cytoreductive surgery and HIPEC as a potentially curative treatment for primary and secondary peritoneal surface malignancies, peritoneal surface oncology has emerged as a distinct sub-specialty of surgical oncology. In the last 10 years, the acceptance of a conceptually different approach towards the management of peritoneal metastases has increased in India. During this period, over 1000 combined procedures have been performed in the country and most of the major cities have centers performing offering this treatment. Indian surgeons have formed collaborative groups to promote research and development of this specialty across the country. This article provides a detailed account of current practices pertaining to peritoneal surface oncology in the country and a future perspective.

Sarin R (2015) Global trends in specialist training, certification, and regulation of oncology practice and its implications for the developing world. J Cancer Res Ther 11:675–678CrossRefPubMed

India State-Level Disease Burden Initiative Collaborators (2017) Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the global burden of disease study. Lancet 390:2437–2460CrossRef

The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Oncol. 2018;19(10):1289–1306

National Cancer Registry Programme (2015) WWW page. URL: http://ncrpindia.org. Last Accessed 2018 Feb 27

Bhatt A, Goéré D (2016) Cytoreductive surgery plus HIPEC for peritoneal metastases from colorectal Cancer. Indian J Surg Oncol 7(2):177–187CrossRefPubMedPubMedCentral

Seshadri RA, Glehen O (2016) The role of Hyperthermic intraperitoneal chemotherapy in gastric Cancer. Indian J Surg Oncol 7(2):198–207CrossRefPubMedPubMedCentral

Bakrin N, Classe JM, Pomel C, Gouy S, Chene G, Glehen O (2014) Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. J Visc Surg 151:347–353. https://doi.org/10.1016/j.jviscsurg.2014.07.005 CrossRefPubMed

Bevan KE, Mohamed F, Moran BJ (2010) Pseudomyxoma peritonei. World J Gastrointest Oncol 2(1):44–50CrossRefPubMedPubMedCentral

Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29–42CrossRefPubMedPubMedCentral

10.

Fujimura T, Yonemura Y, Fushida S et al (1990) Continuous hyperthermic intraperitoneal perfusion for the treatment of peritoneal dissemination in gastric cancer and subsequent second-look operation. Cancer 65(1):65–71CrossRefPubMed

11.

Yamaguchi A, Tsukioka Y, Fushida S, et al. Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancer. Dis Colon Rectum

12.

Koga S, Shimizu N, Maeta M, Hamazoe R, Izumi A (1983) Application of heat combined with antineoplastic agent administration in the treatment of cancer (with special reference to malignancy of the digestive system). Gan to Kagaku Ryoho 10:358–365PubMed

13.

Sayag AC, Gilly FN, Carry PY, Perdrix JP, Panteix G, Brachet A, Banssillon V, Braillon G (1993) Intraoperative chemohyperthermia in the management of digestive cancers. A general review of literature. Oncology 50(5):333–337CrossRefPubMed

14.

Bhatt A, Mehta S, Seshadri RA, Sethna K, Zaveri S, Rajan F, Mahajan V, Singh S, Raj EH, Sugarbaker PH (2016) The initial Indian experience with Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases. Indian J Surg Oncol 7(2):160–165CrossRefPubMedPubMedCentral

15.

Guidelines for import and manufacture of medical devices [Internet]. India. CDSCO. Available at: www.cdsco.nic.in/forms/ list.aspx?lid = 1580&Id = 1. Accessed 12 Nov 2018

16.

Radhadevi N, Balamuralidhara V, Pramod Kumar TM, Ravi V (2012) Regulatory guidelines for medical devices in India: an overview. Asian J Pharm 6:10–17CrossRef

17.

Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5(4):219–228CrossRefPubMed

18.

Veronesi U, Stafyla V (2012) Grand challenges in surgical oncology. Front Oncol 2:127. Published 2012 Oct 2. https://doi.org/10.3389/fonc.2012.00127 CrossRefPubMedPubMedCentral

19.

Smeenk RM, Verwaal VJ, Zoetmulder FA (2007) Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 94:1408–1414. https://doi.org/10.1002/bjs.5863 CrossRefPubMed

20.

Kusamura S, Baratti D, Deraco M (2012) Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg 255(2):348–356. https://doi.org/10.1097/SLA.0b013e3182436c28 CrossRefPubMed

21.

Li Y, Yu Y, Liu Y (2014) Report on the 9th international congress on peritoneal surface malignancies. Cancer Biol Med 11(4):281–284PubMedPubMedCentral

22.

ICRETT – UICChttps://www.uicc.org/sites/main/files/private/ICRETT_Programme_Guidelines.pdf

23.

Pramesh CS, Badwe RA, Borthakur BB, Chandra M, Raj EH, Kannan T, Kalwar A, Kapoor S, Malhotra H, Nayak S, Rath GK, Sagar TG, Sebastian P, Sarin R, Shanta V, Sharma SC, Shukla S, Vijayakumar M, Vijaykumar DK, Aggarwal A, Purushotham A, Sullivan R (2014) Delivery of affordable and equitable cancer care in India. Lancet Oncol 15(6):e223–e233. https://doi.org/10.1016/S1470-2045(14)70117-2 CrossRefPubMed

24.

Thakur J, Prinja S, Garg CC, Mendis S, Menabde N (2011) Social and economic implications of noncommunicable diseases in India. Indian J Community Med 36(suppl 1):S13–S22CrossRefPubMedPubMedCentral

25.

Bhatt A, Prabhu R, Sethna K, Tharayil S, Kumar M (2017) The “homemade” HIPEC [33] machine—a cost-effective alternative in low-resource countries. Pleura and Peritoneum 2:163–170CrossRefPubMedPubMedCentral

26.

Alyami M, Kim BJ, Villeneuve L, Vaudoyer D, Képénékian V, Bakrin N, Gilly FN, Cotte E, Glehen O, Passot G (2018) Ninety-day post-operative [34] morbidity and mortality using the National Cancer Institute’s com- Mon terminology criteria for adverse events better describe post- operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperth 34:532–537CrossRef

27.

Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IHJT, Ceelen WP, Pelz JO, Piso P, González-Moreno S, van der Speeten K, Morris DL (2012) Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456CrossRefPubMed

28.

Villeneuve L, Passot G, Glehen O et al (2017) The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry. Orphanet J Rare Dis 12:37CrossRefPubMedPubMedCentral

29.

Bhatt A, Mehta S, Ramakrishnan AS et al (2017) Setting up of the Indian HIPEC registry: a registry for Indian patients with peritoneal surface malignancies. Indian J Surg Oncol 8:527–532CrossRefPubMedPubMedCentral

30.

Sugarbaker PH (2017) The seven best from PSOGI 2016. Ann Surg Oncol 24:870–874CrossRefPubMed

31.

Bhatt A, Mehta S, Zaveri S, Rajan F, Ray M, Sethna K, Katdare N et al (2018) Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry. Int J Hyperth. https://doi.org/10.1080/02656736.2018.1503345

32.

Bhatt A, Sheshadri D, Chandan G, Ramaswamy V, Pandey J, Bhorkar N, Agrawal D, Mehta S (2017) Outcomes of cytoreductive surgery and HIPEC for pseudomyxoma peritonei of appendiceal origin from two Indian centers: A preliminary five-year experience. J BUON 22(1):251–257PubMed

33.

Bhatt A, George A, Mehta S (2017) CRS and HIPEC for PMP-Use of the LC-CUSUM to Determine the Number of Procedures Required to Attain a Minimal Level of Proficiency in Delivering the Combined Modality Treatment. Indian J Surg Oncol 8(4):533–539. https://doi.org/10.1007/s13193-017-0692-8 CrossRefPubMedPubMedCentral

34.

Gupta N, Asif S, Gandhi J, Rajpurohit S, Singh S (2017) Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience. Indian J Gastroenterol 36:126–130CrossRefPubMed

35.

Somashekhar SP, Prasanna G, Jaka R, Rauthan A, Murthy HS, Karanth S (2016) Hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a single institution Indian experience. Natl Med J India 29(5):262–266PubMed

36.

Bhatt A, Mishra S, Prabhu R, Ramaswamy V, George A, Bhandare S, Shah M, Mehta S (2018) Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification. Eur J Surg Oncol 44(7):1105–1111. https://doi.org/10.1016/j.ejso.2018.03.032 CrossRefPubMed

37.

Bhatt A, Sinukumar S, Zaveri S, Rajan F, Damodaran D, Kammar P, Mehta S (2018) A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer- A study by INDEPSO. Pleura and Peritoneum 2018; 1, Special Suppl, pp sA6–sA463. https://doi.org/10.1515/pap-2018-7013

38.

Pramesh CS, Badwe RA, Sinha RK (2014) The National Cancer Grid of India. Indian J Med Paediatr Oncol 35:226–227CrossRefPubMedPubMedCentral

39.

Katdare N, Prabhu R, Mishra S et al (2018) Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Initial Experience from Indian Centers and a Review of Literature. Indian J Surg Oncol. https://doi.org/10.1007/s13193-018-0771-5

40.

Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D, French Surgical Association (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116(24):5608–5618. https://doi.org/10.1002/cncr.25356 CrossRefPubMed

41.

Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL, Sardi A, Glehen O, Deraco M, Peritoneal Surface Oncology Group International (PSOGI) (2014) Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg 101(13):1758–1765. https://doi.org/10.1002/bjs.9674 CrossRefPubMed

Title: The Current Status of Peritoneal Surface Oncology in India
Authors: Aditi Bhatt
Sanket Mehta
Ramakrishnan Ayaloor Seshadri
Publication date: 01-02-2019
Publisher: Springer India
Keyword: Metastasis
Published in: Indian Journal of Surgical Oncology / Issue Special Issue 1/2019
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-018-00871-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The Current Status of Peritoneal Surface Oncology in India

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2019

Peritoneal Surface Oncology in Singapore

Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO

Current Status of Peritoneal Surface Malignancy in Thailand

Pelvic Exenteration with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS + HIPEC) for Rectal Cancer—Case Series with Review of Literature

Impact of Radicality Versus Timing of Surgery in Patients with Advanced Ovarian Cancer (Stage III C) Undergoing CRS and HIPEC—a Retrospective Study by INDEPSO

The Current Status of Peritoneal Surface Oncology in Saudi Arabia